nodes	percent_of_prediction	percent_of_DWPC	metapath
Buspirone—ABCB1—hematologic cancer	0.0978	1	CbGaD
Buspirone—ABCB1—Lenalidomide—hematologic cancer	0.0187	0.0317	CbGbCtD
Buspirone—CYP3A7-CYP3A51P—Ifosfamide—hematologic cancer	0.018	0.0305	CbGbCtD
Buspirone—CYP3A7—Ifosfamide—hematologic cancer	0.018	0.0305	CbGbCtD
Buspirone—CYP3A7—Imatinib—hematologic cancer	0.0172	0.0292	CbGbCtD
Buspirone—CYP3A7-CYP3A51P—Imatinib—hematologic cancer	0.0172	0.0292	CbGbCtD
Buspirone—CYP3A5—Daunorubicin—hematologic cancer	0.0168	0.0286	CbGbCtD
Buspirone—CYP2D6—Lomustine—hematologic cancer	0.0164	0.0278	CbGbCtD
Buspirone—CYP3A5—Thalidomide—hematologic cancer	0.0153	0.026	CbGbCtD
Buspirone—CYP3A5—Teniposide—hematologic cancer	0.0146	0.0248	CbGbCtD
Buspirone—CYP2D6—Idarubicin—hematologic cancer	0.0146	0.0248	CbGbCtD
Buspirone—CYP3A5—Ifosfamide—hematologic cancer	0.0135	0.0229	CbGbCtD
Buspirone—CYP3A5—Imatinib—hematologic cancer	0.0129	0.0219	CbGbCtD
Buspirone—CYP2D6—Hydroxyurea—hematologic cancer	0.0124	0.021	CbGbCtD
Buspirone—CYP3A4—Bexarotene—hematologic cancer	0.0112	0.019	CbGbCtD
Buspirone—ABCB1—Daunorubicin—hematologic cancer	0.011	0.0186	CbGbCtD
Buspirone—CYP2D6—Bortezomib—hematologic cancer	0.0108	0.0183	CbGbCtD
Buspirone—CYP3A7-CYP3A51P—Irinotecan—hematologic cancer	0.0107	0.0182	CbGbCtD
Buspirone—CYP3A7—Irinotecan—hematologic cancer	0.0107	0.0182	CbGbCtD
Buspirone—ABCB1—Alitretinoin—hematologic cancer	0.0107	0.0182	CbGbCtD
Buspirone—CYP3A4—Lomustine—hematologic cancer	0.0104	0.0177	CbGbCtD
Buspirone—CYP3A4—Busulfan—hematologic cancer	0.0104	0.0177	CbGbCtD
Buspirone—CYP3A5—Dasatinib—hematologic cancer	0.0104	0.0176	CbGbCtD
Buspirone—CYP3A7—Vincristine—hematologic cancer	0.00939	0.0159	CbGbCtD
Buspirone—CYP3A7-CYP3A51P—Vincristine—hematologic cancer	0.00939	0.0159	CbGbCtD
Buspirone—CYP3A4—Thiotepa—hematologic cancer	0.00929	0.0157	CbGbCtD
Buspirone—ABCB1—Imatinib—hematologic cancer	0.0084	0.0142	CbGbCtD
Buspirone—CYP3A5—Irinotecan—hematologic cancer	0.00806	0.0137	CbGbCtD
Buspirone—CYP2D6—Imatinib—hematologic cancer	0.00791	0.0134	CbGbCtD
Buspirone—ABCB1—Nilotinib—hematologic cancer	0.00763	0.0129	CbGbCtD
Buspirone—ABCB1—Vinorelbine—hematologic cancer	0.00757	0.0128	CbGbCtD
Buspirone—CYP3A4—Methoxsalen—hematologic cancer	0.00722	0.0122	CbGbCtD
Buspirone—CYP2D6—Nilotinib—hematologic cancer	0.00719	0.0122	CbGbCtD
Buspirone—CYP2D6—Vinorelbine—hematologic cancer	0.00713	0.0121	CbGbCtD
Buspirone—CYP3A7-CYP3A51P—Dexamethasone—hematologic cancer	0.00708	0.012	CbGbCtD
Buspirone—CYP3A7—Dexamethasone—hematologic cancer	0.00708	0.012	CbGbCtD
Buspirone—CYP3A5—Vincristine—hematologic cancer	0.00705	0.0119	CbGbCtD
Buspirone—CYP3A4—Bortezomib—hematologic cancer	0.00687	0.0116	CbGbCtD
Buspirone—ABCB1—Dasatinib—hematologic cancer	0.00675	0.0114	CbGbCtD
Buspirone—ABCB1—Mitoxantrone—hematologic cancer	0.00666	0.0113	CbGbCtD
Buspirone—CYP3A4—Daunorubicin—hematologic cancer	0.00657	0.0111	CbGbCtD
Buspirone—CYP3A5—Etoposide—hematologic cancer	0.00646	0.0109	CbGbCtD
Buspirone—ABCB1—Betamethasone—hematologic cancer	0.00594	0.0101	CbGbCtD
Buspirone—ABCB1—Gemcitabine—hematologic cancer	0.00589	0.00998	CbGbCtD
Buspirone—ABCB1—Prednisolone—hematologic cancer	0.00586	0.00993	CbGbCtD
Buspirone—CYP3A4—Cytarabine—hematologic cancer	0.0058	0.00982	CbGbCtD
Buspirone—CYP3A4—Teniposide—hematologic cancer	0.00571	0.00968	CbGbCtD
Buspirone—ABCB1—Prednisone—hematologic cancer	0.00553	0.00938	CbGbCtD
Buspirone—CYP3A5—Dexamethasone—hematologic cancer	0.00531	0.009	CbGbCtD
Buspirone—CYP3A4—Ifosfamide—hematologic cancer	0.00527	0.00893	CbGbCtD
Buspirone—ABCB1—Irinotecan—hematologic cancer	0.00525	0.00889	CbGbCtD
Buspirone—CYP3A4—Imatinib—hematologic cancer	0.00503	0.00853	CbGbCtD
Buspirone—CYP3A4—Ruxolitinib—hematologic cancer	0.00474	0.00803	CbGbCtD
Buspirone—ABCB1—Vinblastine—hematologic cancer	0.00466	0.00791	CbGbCtD
Buspirone—ABCB1—Vincristine—hematologic cancer	0.00459	0.00777	CbGbCtD
Buspirone—CYP3A4—Nilotinib—hematologic cancer	0.00457	0.00775	CbGbCtD
Buspirone—CYP3A4—Vinorelbine—hematologic cancer	0.00454	0.00769	CbGbCtD
Buspirone—CYP2D6—Vinblastine—hematologic cancer	0.0044	0.00745	CbGbCtD
Buspirone—ABCB1—Cisplatin—hematologic cancer	0.00428	0.00725	CbGbCtD
Buspirone—ABCB1—Etoposide—hematologic cancer	0.0042	0.00712	CbGbCtD
Buspirone—CYP3A4—Triamcinolone—hematologic cancer	0.00415	0.00703	CbGbCtD
Buspirone—CYP3A4—Dasatinib—hematologic cancer	0.00404	0.00685	CbGbCtD
Buspirone—CYP3A4—Mitoxantrone—hematologic cancer	0.00399	0.00677	CbGbCtD
Buspirone—CYP3A4—Betamethasone—hematologic cancer	0.00356	0.00603	CbGbCtD
Buspirone—CYP3A4—Prednisolone—hematologic cancer	0.00351	0.00595	CbGbCtD
Buspirone—ABCB1—Dexamethasone—hematologic cancer	0.00345	0.00586	CbGbCtD
Buspirone—CYP3A4—Prednisone—hematologic cancer	0.00332	0.00562	CbGbCtD
Buspirone—CYP2D6—Dexamethasone—hematologic cancer	0.00326	0.00552	CbGbCtD
Buspirone—CYP3A4—Irinotecan—hematologic cancer	0.00314	0.00533	CbGbCtD
Buspirone—ABCB1—Doxorubicin—hematologic cancer	0.00287	0.00486	CbGbCtD
Buspirone—CYP3A4—Vinblastine—hematologic cancer	0.00279	0.00474	CbGbCtD
Buspirone—ABCB1—Methotrexate—hematologic cancer	0.00278	0.00471	CbGbCtD
Buspirone—CYP3A4—Vincristine—hematologic cancer	0.00275	0.00466	CbGbCtD
Buspirone—CYP2D6—Doxorubicin—hematologic cancer	0.0027	0.00458	CbGbCtD
Buspirone—CYP3A4—Etoposide—hematologic cancer	0.00252	0.00427	CbGbCtD
Buspirone—CYP3A4—Dexamethasone—hematologic cancer	0.00207	0.00351	CbGbCtD
Buspirone—CYP3A4—Doxorubicin—hematologic cancer	0.00172	0.00291	CbGbCtD
Buspirone—Headache—Gemcitabine—hematologic cancer	3.02e-05	0.000117	CcSEcCtD
Buspirone—Nausea—Vincristine—hematologic cancer	3.02e-05	0.000117	CcSEcCtD
Buspirone—Flushing—Epirubicin—hematologic cancer	3.02e-05	0.000116	CcSEcCtD
Buspirone—Haemorrhage—Doxorubicin—hematologic cancer	3.01e-05	0.000116	CcSEcCtD
Buspirone—Hypersensitivity—Prednisolone—hematologic cancer	2.99e-05	0.000116	CcSEcCtD
Buspirone—Hypoaesthesia—Doxorubicin—hematologic cancer	2.99e-05	0.000116	CcSEcCtD
Buspirone—Dyspepsia—Dexamethasone—hematologic cancer	2.98e-05	0.000115	CcSEcCtD
Buspirone—Dyspepsia—Betamethasone—hematologic cancer	2.98e-05	0.000115	CcSEcCtD
Buspirone—Urticaria—Triamcinolone—hematologic cancer	2.97e-05	0.000115	CcSEcCtD
Buspirone—Dysgeusia—Methotrexate—hematologic cancer	2.96e-05	0.000114	CcSEcCtD
Buspirone—Asthenia—Etoposide—hematologic cancer	2.96e-05	0.000114	CcSEcCtD
Buspirone—Body temperature increased—Triamcinolone—hematologic cancer	2.95e-05	0.000114	CcSEcCtD
Buspirone—Oedema—Prednisone—hematologic cancer	2.95e-05	0.000114	CcSEcCtD
Buspirone—Decreased appetite—Dexamethasone—hematologic cancer	2.95e-05	0.000114	CcSEcCtD
Buspirone—Decreased appetite—Betamethasone—hematologic cancer	2.95e-05	0.000114	CcSEcCtD
Buspirone—Nausea—Mitoxantrone—hematologic cancer	2.94e-05	0.000114	CcSEcCtD
Buspirone—Nausea—Irinotecan—hematologic cancer	2.94e-05	0.000114	CcSEcCtD
Buspirone—Gastrointestinal disorder—Betamethasone—hematologic cancer	2.93e-05	0.000113	CcSEcCtD
Buspirone—Gastrointestinal disorder—Dexamethasone—hematologic cancer	2.93e-05	0.000113	CcSEcCtD
Buspirone—Fatigue—Betamethasone—hematologic cancer	2.92e-05	0.000113	CcSEcCtD
Buspirone—Fatigue—Dexamethasone—hematologic cancer	2.92e-05	0.000113	CcSEcCtD
Buspirone—Chills—Epirubicin—hematologic cancer	2.92e-05	0.000113	CcSEcCtD
Buspirone—Pruritus—Etoposide—hematologic cancer	2.91e-05	0.000113	CcSEcCtD
Buspirone—Shock—Prednisone—hematologic cancer	2.9e-05	0.000112	CcSEcCtD
Buspirone—Pain—Dexamethasone—hematologic cancer	2.9e-05	0.000112	CcSEcCtD
Buspirone—Pain—Betamethasone—hematologic cancer	2.9e-05	0.000112	CcSEcCtD
Buspirone—Tachycardia—Prednisone—hematologic cancer	2.88e-05	0.000111	CcSEcCtD
Buspirone—Alopecia—Epirubicin—hematologic cancer	2.87e-05	0.000111	CcSEcCtD
Buspirone—Nausea—Gemcitabine—hematologic cancer	2.87e-05	0.000111	CcSEcCtD
Buspirone—Vomiting—Cisplatin—hematologic cancer	2.86e-05	0.00011	CcSEcCtD
Buspirone—Hyperhidrosis—Prednisone—hematologic cancer	2.85e-05	0.00011	CcSEcCtD
Buspirone—Vision blurred—Methotrexate—hematologic cancer	2.85e-05	0.00011	CcSEcCtD
Buspirone—Rash—Cisplatin—hematologic cancer	2.83e-05	0.000109	CcSEcCtD
Buspirone—Dermatitis—Cisplatin—hematologic cancer	2.83e-05	0.000109	CcSEcCtD
Buspirone—Erythema—Epirubicin—hematologic cancer	2.83e-05	0.000109	CcSEcCtD
Buspirone—Diarrhoea—Etoposide—hematologic cancer	2.82e-05	0.000109	CcSEcCtD
Buspirone—Anorexia—Prednisone—hematologic cancer	2.81e-05	0.000109	CcSEcCtD
Buspirone—Ill-defined disorder—Methotrexate—hematologic cancer	2.8e-05	0.000108	CcSEcCtD
Buspirone—Tinnitus—Doxorubicin—hematologic cancer	2.8e-05	0.000108	CcSEcCtD
Buspirone—Feeling abnormal—Betamethasone—hematologic cancer	2.79e-05	0.000108	CcSEcCtD
Buspirone—Feeling abnormal—Dexamethasone—hematologic cancer	2.79e-05	0.000108	CcSEcCtD
Buspirone—Flushing—Doxorubicin—hematologic cancer	2.79e-05	0.000108	CcSEcCtD
Buspirone—Flatulence—Epirubicin—hematologic cancer	2.79e-05	0.000108	CcSEcCtD
Buspirone—Tension—Epirubicin—hematologic cancer	2.78e-05	0.000107	CcSEcCtD
Buspirone—Dysgeusia—Epirubicin—hematologic cancer	2.77e-05	0.000107	CcSEcCtD
Buspirone—Hypersensitivity—Triamcinolone—hematologic cancer	2.75e-05	0.000106	CcSEcCtD
Buspirone—Nervousness—Epirubicin—hematologic cancer	2.75e-05	0.000106	CcSEcCtD
Buspirone—Malaise—Methotrexate—hematologic cancer	2.73e-05	0.000105	CcSEcCtD
Buspirone—Dizziness—Etoposide—hematologic cancer	2.72e-05	0.000105	CcSEcCtD
Buspirone—Muscle spasms—Epirubicin—hematologic cancer	2.72e-05	0.000105	CcSEcCtD
Buspirone—Vertigo—Methotrexate—hematologic cancer	2.72e-05	0.000105	CcSEcCtD
Buspirone—Leukopenia—Methotrexate—hematologic cancer	2.71e-05	0.000105	CcSEcCtD
Buspirone—Chills—Doxorubicin—hematologic cancer	2.7e-05	0.000104	CcSEcCtD
Buspirone—Urticaria—Betamethasone—hematologic cancer	2.69e-05	0.000104	CcSEcCtD
Buspirone—Urticaria—Dexamethasone—hematologic cancer	2.69e-05	0.000104	CcSEcCtD
Buspirone—Musculoskeletal discomfort—Prednisone—hematologic cancer	2.69e-05	0.000104	CcSEcCtD
Buspirone—Dizziness—Prednisolone—hematologic cancer	2.69e-05	0.000104	CcSEcCtD
Buspirone—Asthenia—Triamcinolone—hematologic cancer	2.68e-05	0.000104	CcSEcCtD
Buspirone—Body temperature increased—Betamethasone—hematologic cancer	2.68e-05	0.000103	CcSEcCtD
Buspirone—Body temperature increased—Dexamethasone—hematologic cancer	2.68e-05	0.000103	CcSEcCtD
Buspirone—Nausea—Cisplatin—hematologic cancer	2.67e-05	0.000103	CcSEcCtD
Buspirone—Insomnia—Prednisone—hematologic cancer	2.67e-05	0.000103	CcSEcCtD
Buspirone—Vision blurred—Epirubicin—hematologic cancer	2.67e-05	0.000103	CcSEcCtD
Buspirone—Alopecia—Doxorubicin—hematologic cancer	2.66e-05	0.000103	CcSEcCtD
Buspirone—Paraesthesia—Prednisone—hematologic cancer	2.65e-05	0.000102	CcSEcCtD
Buspirone—Pruritus—Triamcinolone—hematologic cancer	2.64e-05	0.000102	CcSEcCtD
Buspirone—Ill-defined disorder—Epirubicin—hematologic cancer	2.62e-05	0.000101	CcSEcCtD
Buspirone—Convulsion—Methotrexate—hematologic cancer	2.62e-05	0.000101	CcSEcCtD
Buspirone—Vomiting—Etoposide—hematologic cancer	2.62e-05	0.000101	CcSEcCtD
Buspirone—Erythema—Doxorubicin—hematologic cancer	2.62e-05	0.000101	CcSEcCtD
Buspirone—Agitation—Epirubicin—hematologic cancer	2.6e-05	0.0001	CcSEcCtD
Buspirone—Dyspepsia—Prednisone—hematologic cancer	2.6e-05	0.0001	CcSEcCtD
Buspirone—Rash—Etoposide—hematologic cancer	2.6e-05	0.0001	CcSEcCtD
Buspirone—Dermatitis—Etoposide—hematologic cancer	2.59e-05	0.0001	CcSEcCtD
Buspirone—Headache—Etoposide—hematologic cancer	2.58e-05	9.97e-05	CcSEcCtD
Buspirone—Flatulence—Doxorubicin—hematologic cancer	2.58e-05	9.96e-05	CcSEcCtD
Buspirone—Arthralgia—Methotrexate—hematologic cancer	2.57e-05	9.94e-05	CcSEcCtD
Buspirone—Myalgia—Methotrexate—hematologic cancer	2.57e-05	9.94e-05	CcSEcCtD
Buspirone—Chest pain—Methotrexate—hematologic cancer	2.57e-05	9.94e-05	CcSEcCtD
Buspirone—Tension—Doxorubicin—hematologic cancer	2.57e-05	9.92e-05	CcSEcCtD
Buspirone—Decreased appetite—Prednisone—hematologic cancer	2.57e-05	9.91e-05	CcSEcCtD
Buspirone—Dysgeusia—Doxorubicin—hematologic cancer	2.56e-05	9.9e-05	CcSEcCtD
Buspirone—Rash—Prednisolone—hematologic cancer	2.56e-05	9.89e-05	CcSEcCtD
Buspirone—Dermatitis—Prednisolone—hematologic cancer	2.56e-05	9.88e-05	CcSEcCtD
Buspirone—Malaise—Epirubicin—hematologic cancer	2.55e-05	9.85e-05	CcSEcCtD
Buspirone—Fatigue—Prednisone—hematologic cancer	2.55e-05	9.83e-05	CcSEcCtD
Buspirone—Headache—Prednisolone—hematologic cancer	2.55e-05	9.83e-05	CcSEcCtD
Buspirone—Discomfort—Methotrexate—hematologic cancer	2.54e-05	9.82e-05	CcSEcCtD
Buspirone—Nervousness—Doxorubicin—hematologic cancer	2.54e-05	9.82e-05	CcSEcCtD
Buspirone—Vertigo—Epirubicin—hematologic cancer	2.54e-05	9.82e-05	CcSEcCtD
Buspirone—Syncope—Epirubicin—hematologic cancer	2.54e-05	9.8e-05	CcSEcCtD
Buspirone—Leukopenia—Epirubicin—hematologic cancer	2.53e-05	9.78e-05	CcSEcCtD
Buspirone—Constipation—Prednisone—hematologic cancer	2.52e-05	9.75e-05	CcSEcCtD
Buspirone—Muscle spasms—Doxorubicin—hematologic cancer	2.52e-05	9.72e-05	CcSEcCtD
Buspirone—Palpitations—Epirubicin—hematologic cancer	2.5e-05	9.66e-05	CcSEcCtD
Buspirone—Confusional state—Methotrexate—hematologic cancer	2.49e-05	9.61e-05	CcSEcCtD
Buspirone—Loss of consciousness—Epirubicin—hematologic cancer	2.49e-05	9.6e-05	CcSEcCtD
Buspirone—Dizziness—Triamcinolone—hematologic cancer	2.47e-05	9.54e-05	CcSEcCtD
Buspirone—Vision blurred—Doxorubicin—hematologic cancer	2.47e-05	9.53e-05	CcSEcCtD
Buspirone—Convulsion—Epirubicin—hematologic cancer	2.45e-05	9.47e-05	CcSEcCtD
Buspirone—Nausea—Etoposide—hematologic cancer	2.45e-05	9.45e-05	CcSEcCtD
Buspirone—Hypertension—Epirubicin—hematologic cancer	2.44e-05	9.43e-05	CcSEcCtD
Buspirone—Feeling abnormal—Prednisone—hematologic cancer	2.43e-05	9.4e-05	CcSEcCtD
Buspirone—Asthenia—Dexamethasone—hematologic cancer	2.43e-05	9.39e-05	CcSEcCtD
Buspirone—Asthenia—Betamethasone—hematologic cancer	2.43e-05	9.39e-05	CcSEcCtD
Buspirone—Ill-defined disorder—Doxorubicin—hematologic cancer	2.43e-05	9.38e-05	CcSEcCtD
Buspirone—Thrombocytopenia—Methotrexate—hematologic cancer	2.42e-05	9.33e-05	CcSEcCtD
Buspirone—Nausea—Prednisolone—hematologic cancer	2.41e-05	9.32e-05	CcSEcCtD
Buspirone—Myalgia—Epirubicin—hematologic cancer	2.41e-05	9.3e-05	CcSEcCtD
Buspirone—Chest pain—Epirubicin—hematologic cancer	2.41e-05	9.3e-05	CcSEcCtD
Buspirone—Arthralgia—Epirubicin—hematologic cancer	2.41e-05	9.3e-05	CcSEcCtD
Buspirone—Agitation—Doxorubicin—hematologic cancer	2.41e-05	9.29e-05	CcSEcCtD
Buspirone—Pruritus—Dexamethasone—hematologic cancer	2.4e-05	9.26e-05	CcSEcCtD
Buspirone—Pruritus—Betamethasone—hematologic cancer	2.4e-05	9.26e-05	CcSEcCtD
Buspirone—Hyperhidrosis—Methotrexate—hematologic cancer	2.39e-05	9.21e-05	CcSEcCtD
Buspirone—Discomfort—Epirubicin—hematologic cancer	2.38e-05	9.19e-05	CcSEcCtD
Buspirone—Vomiting—Triamcinolone—hematologic cancer	2.38e-05	9.17e-05	CcSEcCtD
Buspirone—Malaise—Doxorubicin—hematologic cancer	2.36e-05	9.12e-05	CcSEcCtD
Buspirone—Rash—Triamcinolone—hematologic cancer	2.36e-05	9.1e-05	CcSEcCtD
Buspirone—Dry mouth—Epirubicin—hematologic cancer	2.36e-05	9.1e-05	CcSEcCtD
Buspirone—Dermatitis—Triamcinolone—hematologic cancer	2.35e-05	9.09e-05	CcSEcCtD
Buspirone—Vertigo—Doxorubicin—hematologic cancer	2.35e-05	9.08e-05	CcSEcCtD
Buspirone—Anorexia—Methotrexate—hematologic cancer	2.35e-05	9.08e-05	CcSEcCtD
Buspirone—Syncope—Doxorubicin—hematologic cancer	2.35e-05	9.07e-05	CcSEcCtD
Buspirone—Urticaria—Prednisone—hematologic cancer	2.35e-05	9.06e-05	CcSEcCtD
Buspirone—Leukopenia—Doxorubicin—hematologic cancer	2.34e-05	9.05e-05	CcSEcCtD
Buspirone—Headache—Triamcinolone—hematologic cancer	2.34e-05	9.04e-05	CcSEcCtD
Buspirone—Body temperature increased—Prednisone—hematologic cancer	2.33e-05	9.01e-05	CcSEcCtD
Buspirone—Confusional state—Epirubicin—hematologic cancer	2.33e-05	8.99e-05	CcSEcCtD
Buspirone—Diarrhoea—Dexamethasone—hematologic cancer	2.32e-05	8.96e-05	CcSEcCtD
Buspirone—Diarrhoea—Betamethasone—hematologic cancer	2.32e-05	8.96e-05	CcSEcCtD
Buspirone—Palpitations—Doxorubicin—hematologic cancer	2.31e-05	8.93e-05	CcSEcCtD
Buspirone—Oedema—Epirubicin—hematologic cancer	2.31e-05	8.92e-05	CcSEcCtD
Buspirone—Hypotension—Methotrexate—hematologic cancer	2.31e-05	8.9e-05	CcSEcCtD
Buspirone—Loss of consciousness—Doxorubicin—hematologic cancer	2.3e-05	8.89e-05	CcSEcCtD
Buspirone—Shock—Epirubicin—hematologic cancer	2.27e-05	8.77e-05	CcSEcCtD
Buspirone—Convulsion—Doxorubicin—hematologic cancer	2.27e-05	8.76e-05	CcSEcCtD
Buspirone—Thrombocytopenia—Epirubicin—hematologic cancer	2.26e-05	8.73e-05	CcSEcCtD
Buspirone—Hypertension—Doxorubicin—hematologic cancer	2.26e-05	8.73e-05	CcSEcCtD
Buspirone—Tachycardia—Epirubicin—hematologic cancer	2.25e-05	8.7e-05	CcSEcCtD
Buspirone—Musculoskeletal discomfort—Methotrexate—hematologic cancer	2.25e-05	8.68e-05	CcSEcCtD
Buspirone—Dizziness—Dexamethasone—hematologic cancer	2.24e-05	8.66e-05	CcSEcCtD
Buspirone—Dizziness—Betamethasone—hematologic cancer	2.24e-05	8.66e-05	CcSEcCtD
Buspirone—Hyperhidrosis—Epirubicin—hematologic cancer	2.23e-05	8.62e-05	CcSEcCtD
Buspirone—Insomnia—Methotrexate—hematologic cancer	2.23e-05	8.62e-05	CcSEcCtD
Buspirone—Chest pain—Doxorubicin—hematologic cancer	2.23e-05	8.61e-05	CcSEcCtD
Buspirone—Arthralgia—Doxorubicin—hematologic cancer	2.23e-05	8.61e-05	CcSEcCtD
Buspirone—Myalgia—Doxorubicin—hematologic cancer	2.23e-05	8.61e-05	CcSEcCtD
Buspirone—Nausea—Triamcinolone—hematologic cancer	2.22e-05	8.57e-05	CcSEcCtD
Buspirone—Paraesthesia—Methotrexate—hematologic cancer	2.22e-05	8.56e-05	CcSEcCtD
Buspirone—Discomfort—Doxorubicin—hematologic cancer	2.2e-05	8.5e-05	CcSEcCtD
Buspirone—Anorexia—Epirubicin—hematologic cancer	2.2e-05	8.5e-05	CcSEcCtD
Buspirone—Dyspnoea—Methotrexate—hematologic cancer	2.2e-05	8.49e-05	CcSEcCtD
Buspirone—Somnolence—Methotrexate—hematologic cancer	2.19e-05	8.47e-05	CcSEcCtD
Buspirone—Dry mouth—Doxorubicin—hematologic cancer	2.18e-05	8.42e-05	CcSEcCtD
Buspirone—Hypersensitivity—Prednisone—hematologic cancer	2.18e-05	8.4e-05	CcSEcCtD
Buspirone—Dyspepsia—Methotrexate—hematologic cancer	2.17e-05	8.39e-05	CcSEcCtD
Buspirone—Hypotension—Epirubicin—hematologic cancer	2.16e-05	8.33e-05	CcSEcCtD
Buspirone—Vomiting—Betamethasone—hematologic cancer	2.16e-05	8.32e-05	CcSEcCtD
Buspirone—Vomiting—Dexamethasone—hematologic cancer	2.16e-05	8.32e-05	CcSEcCtD
Buspirone—Confusional state—Doxorubicin—hematologic cancer	2.15e-05	8.32e-05	CcSEcCtD
Buspirone—Decreased appetite—Methotrexate—hematologic cancer	2.14e-05	8.28e-05	CcSEcCtD
Buspirone—Rash—Betamethasone—hematologic cancer	2.14e-05	8.25e-05	CcSEcCtD
Buspirone—Rash—Dexamethasone—hematologic cancer	2.14e-05	8.25e-05	CcSEcCtD
Buspirone—Oedema—Doxorubicin—hematologic cancer	2.14e-05	8.25e-05	CcSEcCtD
Buspirone—Dermatitis—Dexamethasone—hematologic cancer	2.14e-05	8.25e-05	CcSEcCtD
Buspirone—Dermatitis—Betamethasone—hematologic cancer	2.14e-05	8.25e-05	CcSEcCtD
Buspirone—Gastrointestinal disorder—Methotrexate—hematologic cancer	2.13e-05	8.23e-05	CcSEcCtD
Buspirone—Fatigue—Methotrexate—hematologic cancer	2.13e-05	8.21e-05	CcSEcCtD
Buspirone—Headache—Dexamethasone—hematologic cancer	2.12e-05	8.2e-05	CcSEcCtD
Buspirone—Headache—Betamethasone—hematologic cancer	2.12e-05	8.2e-05	CcSEcCtD
Buspirone—Asthenia—Prednisone—hematologic cancer	2.12e-05	8.18e-05	CcSEcCtD
Buspirone—Pain—Methotrexate—hematologic cancer	2.11e-05	8.15e-05	CcSEcCtD
Buspirone—Musculoskeletal discomfort—Epirubicin—hematologic cancer	2.1e-05	8.12e-05	CcSEcCtD
Buspirone—Shock—Doxorubicin—hematologic cancer	2.1e-05	8.12e-05	CcSEcCtD
Buspirone—Thrombocytopenia—Doxorubicin—hematologic cancer	2.09e-05	8.08e-05	CcSEcCtD
Buspirone—Pruritus—Prednisone—hematologic cancer	2.09e-05	8.07e-05	CcSEcCtD
Buspirone—Insomnia—Epirubicin—hematologic cancer	2.09e-05	8.06e-05	CcSEcCtD
Buspirone—Tachycardia—Doxorubicin—hematologic cancer	2.09e-05	8.05e-05	CcSEcCtD
Buspirone—Paraesthesia—Epirubicin—hematologic cancer	2.07e-05	8.01e-05	CcSEcCtD
Buspirone—Hyperhidrosis—Doxorubicin—hematologic cancer	2.07e-05	7.98e-05	CcSEcCtD
Buspirone—Dyspnoea—Epirubicin—hematologic cancer	2.06e-05	7.95e-05	CcSEcCtD
Buspirone—Somnolence—Epirubicin—hematologic cancer	2.05e-05	7.93e-05	CcSEcCtD
Buspirone—Anorexia—Doxorubicin—hematologic cancer	2.04e-05	7.86e-05	CcSEcCtD
Buspirone—Feeling abnormal—Methotrexate—hematologic cancer	2.03e-05	7.85e-05	CcSEcCtD
Buspirone—Dyspepsia—Epirubicin—hematologic cancer	2.03e-05	7.85e-05	CcSEcCtD
Buspirone—Diarrhoea—Prednisone—hematologic cancer	2.02e-05	7.8e-05	CcSEcCtD
Buspirone—Nausea—Betamethasone—hematologic cancer	2.01e-05	7.78e-05	CcSEcCtD
Buspirone—Nausea—Dexamethasone—hematologic cancer	2.01e-05	7.78e-05	CcSEcCtD
Buspirone—Decreased appetite—Epirubicin—hematologic cancer	2.01e-05	7.75e-05	CcSEcCtD
Buspirone—Hypotension—Doxorubicin—hematologic cancer	2e-05	7.71e-05	CcSEcCtD
Buspirone—Gastrointestinal disorder—Epirubicin—hematologic cancer	1.99e-05	7.7e-05	CcSEcCtD
Buspirone—Fatigue—Epirubicin—hematologic cancer	1.99e-05	7.69e-05	CcSEcCtD
Buspirone—Pain—Epirubicin—hematologic cancer	1.97e-05	7.63e-05	CcSEcCtD
Buspirone—Constipation—Epirubicin—hematologic cancer	1.97e-05	7.63e-05	CcSEcCtD
Buspirone—Urticaria—Methotrexate—hematologic cancer	1.96e-05	7.57e-05	CcSEcCtD
Buspirone—Dizziness—Prednisone—hematologic cancer	1.95e-05	7.54e-05	CcSEcCtD
Buspirone—Body temperature increased—Methotrexate—hematologic cancer	1.95e-05	7.53e-05	CcSEcCtD
Buspirone—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	1.95e-05	7.52e-05	CcSEcCtD
Buspirone—Insomnia—Doxorubicin—hematologic cancer	1.93e-05	7.46e-05	CcSEcCtD
Buspirone—Paraesthesia—Doxorubicin—hematologic cancer	1.92e-05	7.41e-05	CcSEcCtD
Buspirone—Dyspnoea—Doxorubicin—hematologic cancer	1.9e-05	7.36e-05	CcSEcCtD
Buspirone—Feeling abnormal—Epirubicin—hematologic cancer	1.9e-05	7.35e-05	CcSEcCtD
Buspirone—Somnolence—Doxorubicin—hematologic cancer	1.9e-05	7.33e-05	CcSEcCtD
Buspirone—Dyspepsia—Doxorubicin—hematologic cancer	1.88e-05	7.26e-05	CcSEcCtD
Buspirone—Vomiting—Prednisone—hematologic cancer	1.88e-05	7.25e-05	CcSEcCtD
Buspirone—Rash—Prednisone—hematologic cancer	1.86e-05	7.19e-05	CcSEcCtD
Buspirone—Dermatitis—Prednisone—hematologic cancer	1.86e-05	7.18e-05	CcSEcCtD
Buspirone—Decreased appetite—Doxorubicin—hematologic cancer	1.86e-05	7.17e-05	CcSEcCtD
Buspirone—Headache—Prednisone—hematologic cancer	1.85e-05	7.14e-05	CcSEcCtD
Buspirone—Gastrointestinal disorder—Doxorubicin—hematologic cancer	1.84e-05	7.12e-05	CcSEcCtD
Buspirone—Fatigue—Doxorubicin—hematologic cancer	1.84e-05	7.11e-05	CcSEcCtD
Buspirone—Urticaria—Epirubicin—hematologic cancer	1.83e-05	7.08e-05	CcSEcCtD
Buspirone—Constipation—Doxorubicin—hematologic cancer	1.83e-05	7.06e-05	CcSEcCtD
Buspirone—Pain—Doxorubicin—hematologic cancer	1.83e-05	7.06e-05	CcSEcCtD
Buspirone—Body temperature increased—Epirubicin—hematologic cancer	1.83e-05	7.05e-05	CcSEcCtD
Buspirone—Hypersensitivity—Methotrexate—hematologic cancer	1.82e-05	7.02e-05	CcSEcCtD
Buspirone—Asthenia—Methotrexate—hematologic cancer	1.77e-05	6.84e-05	CcSEcCtD
Buspirone—Feeling abnormal—Doxorubicin—hematologic cancer	1.76e-05	6.8e-05	CcSEcCtD
Buspirone—Nausea—Prednisone—hematologic cancer	1.75e-05	6.77e-05	CcSEcCtD
Buspirone—Pruritus—Methotrexate—hematologic cancer	1.75e-05	6.74e-05	CcSEcCtD
Buspirone—Hypersensitivity—Epirubicin—hematologic cancer	1.7e-05	6.57e-05	CcSEcCtD
Buspirone—Urticaria—Doxorubicin—hematologic cancer	1.7e-05	6.55e-05	CcSEcCtD
Buspirone—Body temperature increased—Doxorubicin—hematologic cancer	1.69e-05	6.52e-05	CcSEcCtD
Buspirone—Diarrhoea—Methotrexate—hematologic cancer	1.69e-05	6.52e-05	CcSEcCtD
Buspirone—Asthenia—Epirubicin—hematologic cancer	1.66e-05	6.4e-05	CcSEcCtD
Buspirone—Pruritus—Epirubicin—hematologic cancer	1.63e-05	6.31e-05	CcSEcCtD
Buspirone—Dizziness—Methotrexate—hematologic cancer	1.63e-05	6.3e-05	CcSEcCtD
Buspirone—Diarrhoea—Epirubicin—hematologic cancer	1.58e-05	6.1e-05	CcSEcCtD
Buspirone—Hypersensitivity—Doxorubicin—hematologic cancer	1.57e-05	6.08e-05	CcSEcCtD
Buspirone—Vomiting—Methotrexate—hematologic cancer	1.57e-05	6.06e-05	CcSEcCtD
Buspirone—Rash—Methotrexate—hematologic cancer	1.56e-05	6.01e-05	CcSEcCtD
Buspirone—Dermatitis—Methotrexate—hematologic cancer	1.55e-05	6e-05	CcSEcCtD
Buspirone—Headache—Methotrexate—hematologic cancer	1.55e-05	5.97e-05	CcSEcCtD
Buspirone—Asthenia—Doxorubicin—hematologic cancer	1.53e-05	5.92e-05	CcSEcCtD
Buspirone—Dizziness—Epirubicin—hematologic cancer	1.53e-05	5.9e-05	CcSEcCtD
Buspirone—Pruritus—Doxorubicin—hematologic cancer	1.51e-05	5.84e-05	CcSEcCtD
Buspirone—Vomiting—Epirubicin—hematologic cancer	1.47e-05	5.67e-05	CcSEcCtD
Buspirone—Nausea—Methotrexate—hematologic cancer	1.47e-05	5.66e-05	CcSEcCtD
Buspirone—Diarrhoea—Doxorubicin—hematologic cancer	1.46e-05	5.65e-05	CcSEcCtD
Buspirone—Rash—Epirubicin—hematologic cancer	1.46e-05	5.62e-05	CcSEcCtD
Buspirone—Dermatitis—Epirubicin—hematologic cancer	1.45e-05	5.62e-05	CcSEcCtD
Buspirone—Headache—Epirubicin—hematologic cancer	1.45e-05	5.59e-05	CcSEcCtD
Buspirone—Dizziness—Doxorubicin—hematologic cancer	1.41e-05	5.46e-05	CcSEcCtD
Buspirone—Nausea—Epirubicin—hematologic cancer	1.37e-05	5.3e-05	CcSEcCtD
Buspirone—Vomiting—Doxorubicin—hematologic cancer	1.36e-05	5.25e-05	CcSEcCtD
Buspirone—Rash—Doxorubicin—hematologic cancer	1.35e-05	5.2e-05	CcSEcCtD
Buspirone—Dermatitis—Doxorubicin—hematologic cancer	1.35e-05	5.2e-05	CcSEcCtD
Buspirone—Headache—Doxorubicin—hematologic cancer	1.34e-05	5.17e-05	CcSEcCtD
Buspirone—Nausea—Doxorubicin—hematologic cancer	1.27e-05	4.9e-05	CcSEcCtD
Buspirone—HTR2B—Signaling Pathways—CDKN1B—hematologic cancer	3.64e-06	6.82e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—MAP2K1—hematologic cancer	3.63e-06	6.81e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—NOTCH1—hematologic cancer	3.62e-06	6.8e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—CD80—hematologic cancer	3.61e-06	6.77e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—MTOR—hematologic cancer	3.61e-06	6.76e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—PIK3CB—hematologic cancer	3.61e-06	6.76e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—PIK3CD—hematologic cancer	3.61e-06	6.76e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—PIK3CG—hematologic cancer	3.6e-06	6.76e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—KIT—hematologic cancer	3.6e-06	6.76e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling by GPCR—NRAS—hematologic cancer	3.6e-06	6.76e-05	CbGpPWpGaD
Buspirone—HTR2B—GPCR downstream signaling—AKT1—hematologic cancer	3.6e-06	6.75e-05	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—GSTM1—hematologic cancer	3.59e-06	6.74e-05	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—NCOR1—hematologic cancer	3.59e-06	6.74e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—ENO2—hematologic cancer	3.58e-06	6.72e-05	CbGpPWpGaD
Buspirone—HTR1A—GPCR downstream signaling—PIK3CA—hematologic cancer	3.57e-06	6.7e-05	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—CASP3—hematologic cancer	3.57e-06	6.69e-05	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—IL2—hematologic cancer	3.56e-06	6.68e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—CD80—hematologic cancer	3.55e-06	6.66e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—PIK3CG—hematologic cancer	3.54e-06	6.65e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—KIT—hematologic cancer	3.54e-06	6.65e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling by GPCR—NRAS—hematologic cancer	3.54e-06	6.65e-05	CbGpPWpGaD
Buspirone—HTR2B—Signaling by GPCR—IL6—hematologic cancer	3.54e-06	6.64e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—PTPN11—hematologic cancer	3.54e-06	6.64e-05	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—PIK3CG—hematologic cancer	3.53e-06	6.63e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling by GPCR—KRAS—hematologic cancer	3.53e-06	6.62e-05	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—ABCB1—hematologic cancer	3.49e-06	6.54e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—PTPN11—hematologic cancer	3.48e-06	6.53e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—GSTT1—hematologic cancer	3.47e-06	6.51e-05	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—CCND1—hematologic cancer	3.47e-06	6.51e-05	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—JUN—hematologic cancer	3.46e-06	6.5e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—FGF2—hematologic cancer	3.45e-06	6.48e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling by GPCR—MAPK3—hematologic cancer	3.45e-06	6.47e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling by GPCR—HRAS—hematologic cancer	3.44e-06	6.46e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—CREB1—hematologic cancer	3.43e-06	6.43e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—PIK3R1—hematologic cancer	3.41e-06	6.39e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—SDC1—hematologic cancer	3.4e-06	6.37e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling by GPCR—MAPK3—hematologic cancer	3.39e-06	6.37e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—BRAF—hematologic cancer	3.39e-06	6.35e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—CDKN1B—hematologic cancer	3.39e-06	6.35e-05	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—GSTM1—hematologic cancer	3.38e-06	6.35e-05	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—NCOR1—hematologic cancer	3.38e-06	6.35e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—CREB1—hematologic cancer	3.37e-06	6.33e-05	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—CDKN1A—hematologic cancer	3.36e-06	6.3e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—CCL2—hematologic cancer	3.36e-06	6.29e-05	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—PTEN—hematologic cancer	3.35e-06	6.28e-05	CbGpPWpGaD
Buspirone—DRD3—GPCR downstream signaling—AKT1—hematologic cancer	3.35e-06	6.28e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—IL6R—hematologic cancer	3.35e-06	6.27e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—CREBBP—hematologic cancer	3.34e-06	6.26e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—BRAF—hematologic cancer	3.33e-06	6.25e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—CASP3—hematologic cancer	3.32e-06	6.22e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—IL2—hematologic cancer	3.31e-06	6.21e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—JAK2—hematologic cancer	3.31e-06	6.21e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—CCL2—hematologic cancer	3.3e-06	6.19e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling by GPCR—IL6—hematologic cancer	3.3e-06	6.18e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—IL6R—hematologic cancer	3.29e-06	6.17e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—CREBBP—hematologic cancer	3.29e-06	6.16e-05	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—MAPK8—hematologic cancer	3.28e-06	6.15e-05	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—CREBBP—hematologic cancer	3.28e-06	6.14e-05	CbGpPWpGaD
Buspirone—HTR2B—Signaling by GPCR—AKT1—hematologic cancer	3.27e-06	6.13e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling by GPCR—PIK3CA—hematologic cancer	3.24e-06	6.08e-05	CbGpPWpGaD
Buspirone—CYP3A7—Metabolism—PTEN—hematologic cancer	3.24e-06	6.07e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—MDM2—hematologic cancer	3.23e-06	6.06e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—CCND1—hematologic cancer	3.23e-06	6.06e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—JUN—hematologic cancer	3.22e-06	6.04e-05	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—EP300—hematologic cancer	3.19e-06	5.99e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—MAP2K1—hematologic cancer	3.19e-06	5.98e-05	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—MTHFR—hematologic cancer	3.17e-06	5.95e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—PIK3CD—hematologic cancer	3.17e-06	5.94e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—MTOR—hematologic cancer	3.14e-06	5.9e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—PIK3CB—hematologic cancer	3.14e-06	5.9e-05	CbGpPWpGaD
Buspirone—DRD2—GPCR downstream signaling—PIK3CA—hematologic cancer	3.14e-06	5.88e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—MAP2K1—hematologic cancer	3.14e-06	5.88e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—CDKN1A—hematologic cancer	3.12e-06	5.86e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—PTEN—hematologic cancer	3.12e-06	5.85e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—PIK3CD—hematologic cancer	3.12e-06	5.84e-05	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—PIK3CD—hematologic cancer	3.11e-06	5.83e-05	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—SRC—hematologic cancer	3.11e-06	5.83e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling by GPCR—KRAS—hematologic cancer	3.1e-06	5.81e-05	CbGpPWpGaD
Buspirone—CYP3A7—Metabolism—EP300—hematologic cancer	3.09e-06	5.79e-05	CbGpPWpGaD
Buspirone—HTR2A—GPCR downstream signaling—PIK3CA—hematologic cancer	3.09e-06	5.79e-05	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—ALB—hematologic cancer	3.07e-06	5.75e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling by GPCR—KRAS—hematologic cancer	3.05e-06	5.72e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—MAPK8—hematologic cancer	3.05e-06	5.72e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling by GPCR—AKT1—hematologic cancer	3.04e-06	5.7e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—FGF2—hematologic cancer	3.03e-06	5.69e-05	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—VEGFA—hematologic cancer	3.03e-06	5.67e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling by GPCR—HRAS—hematologic cancer	3e-06	5.63e-05	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—STAT3—hematologic cancer	3e-06	5.62e-05	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—MTHFR—hematologic cancer	2.99e-06	5.61e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—PIK3R1—hematologic cancer	2.99e-06	5.61e-05	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—NRAS—hematologic cancer	2.99e-06	5.6e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—FGF2—hematologic cancer	2.98e-06	5.6e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—EP300—hematologic cancer	2.97e-06	5.57e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—CDKN1B—hematologic cancer	2.95e-06	5.53e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—PIK3R1—hematologic cancer	2.94e-06	5.52e-05	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—PIK3R1—hematologic cancer	2.93e-06	5.5e-05	CbGpPWpGaD
Buspirone—HTR1A—GPCR downstream signaling—AKT1—hematologic cancer	2.92e-06	5.47e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—JAK2—hematologic cancer	2.91e-06	5.45e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—CASP3—hematologic cancer	2.89e-06	5.42e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—SRC—hematologic cancer	2.89e-06	5.42e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—IL2—hematologic cancer	2.89e-06	5.41e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—NQO1—hematologic cancer	2.89e-06	5.41e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—CD44—hematologic cancer	2.89e-06	5.41e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling by GPCR—IL6—hematologic cancer	2.87e-06	5.39e-05	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—MAPK3—hematologic cancer	2.86e-06	5.37e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—JAK2—hematologic cancer	2.86e-06	5.36e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling by GPCR—PIK3CA—hematologic cancer	2.85e-06	5.34e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—MDM2—hematologic cancer	2.84e-06	5.32e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—VEGFA—hematologic cancer	2.82e-06	5.28e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—CCND1—hematologic cancer	2.81e-06	5.28e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—JUN—hematologic cancer	2.81e-06	5.27e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling by GPCR—PIK3CA—hematologic cancer	2.8e-06	5.26e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—MDM2—hematologic cancer	2.79e-06	5.24e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—STAT3—hematologic cancer	2.79e-06	5.23e-05	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—MYC—hematologic cancer	2.78e-06	5.22e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—NRAS—hematologic cancer	2.78e-06	5.22e-05	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—TGFB1—hematologic cancer	2.78e-06	5.21e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—MTOR—hematologic cancer	2.76e-06	5.18e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—PIK3CB—hematologic cancer	2.76e-06	5.18e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—CYCS—hematologic cancer	2.73e-06	5.12e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—CDKN1A—hematologic cancer	2.72e-06	5.11e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—PTEN—hematologic cancer	2.72e-06	5.09e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—PIK3CB—hematologic cancer	2.72e-06	5.09e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—MTOR—hematologic cancer	2.72e-06	5.09e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	2.71e-06	5.09e-05	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—PIK3CB—hematologic cancer	2.71e-06	5.08e-05	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—PIK3CG—hematologic cancer	2.67e-06	5e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—MAPK3—hematologic cancer	2.66e-06	4.99e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—MAPK8—hematologic cancer	2.66e-06	4.98e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling by GPCR—AKT1—hematologic cancer	2.65e-06	4.97e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling by GPCR—HRAS—hematologic cancer	2.64e-06	4.94e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling by GPCR—HRAS—hematologic cancer	2.59e-06	4.86e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—EP300—hematologic cancer	2.59e-06	4.86e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—CDKN1B—hematologic cancer	2.59e-06	4.86e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—MYC—hematologic cancer	2.59e-06	4.86e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—TGFB1—hematologic cancer	2.58e-06	4.85e-05	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—KRAS—hematologic cancer	2.57e-06	4.82e-05	CbGpPWpGaD
Buspirone—DRD2—GPCR downstream signaling—AKT1—hematologic cancer	2.56e-06	4.81e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—CDKN1B—hematologic cancer	2.55e-06	4.78e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—CASP3—hematologic cancer	2.54e-06	4.76e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—IL2—hematologic cancer	2.54e-06	4.75e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling by GPCR—IL6—hematologic cancer	2.52e-06	4.73e-05	CbGpPWpGaD
Buspirone—HTR2A—GPCR downstream signaling—AKT1—hematologic cancer	2.52e-06	4.73e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—SRC—hematologic cancer	2.52e-06	4.72e-05	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—PIK3CG—hematologic cancer	2.51e-06	4.71e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—CASP3—hematologic cancer	2.5e-06	4.68e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—IL2—hematologic cancer	2.49e-06	4.68e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling by GPCR—IL6—hematologic cancer	2.48e-06	4.65e-05	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—CREBBP—hematologic cancer	2.47e-06	4.64e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—CCND1—hematologic cancer	2.47e-06	4.63e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—JUN—hematologic cancer	2.47e-06	4.62e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—VEGFA—hematologic cancer	2.45e-06	4.6e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—CCND1—hematologic cancer	2.43e-06	4.56e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—STAT3—hematologic cancer	2.43e-06	4.56e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—JUN—hematologic cancer	2.43e-06	4.55e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—NRAS—hematologic cancer	2.42e-06	4.55e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—GSTP1—hematologic cancer	2.41e-06	4.52e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—KRAS—hematologic cancer	2.39e-06	4.49e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—CDKN1A—hematologic cancer	2.39e-06	4.48e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—PTEN—hematologic cancer	2.39e-06	4.47e-05	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—PIK3CA—hematologic cancer	2.36e-06	4.43e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—CDKN1A—hematologic cancer	2.35e-06	4.41e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—PTEN—hematologic cancer	2.35e-06	4.4e-05	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—PIK3CD—hematologic cancer	2.34e-06	4.4e-05	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—PTEN—hematologic cancer	2.34e-06	4.39e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—MAPK8—hematologic cancer	2.33e-06	4.38e-05	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—CREBBP—hematologic cancer	2.33e-06	4.37e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling by GPCR—AKT1—hematologic cancer	2.33e-06	4.36e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—MAPK3—hematologic cancer	2.32e-06	4.35e-05	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—ALB—hematologic cancer	2.31e-06	4.34e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—MAPK8—hematologic cancer	2.3e-06	4.31e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling by GPCR—AKT1—hematologic cancer	2.29e-06	4.29e-05	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—TP53—hematologic cancer	2.29e-06	4.29e-05	CbGpPWpGaD
Buspirone—CYP3A7—Metabolism—PIK3CA—hematologic cancer	2.28e-06	4.28e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—ABCB1—hematologic cancer	2.28e-06	4.27e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—EP300—hematologic cancer	2.27e-06	4.27e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—MYC—hematologic cancer	2.26e-06	4.23e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—TGFB1—hematologic cancer	2.25e-06	4.22e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—EP300—hematologic cancer	2.24e-06	4.2e-05	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—EP300—hematologic cancer	2.23e-06	4.19e-05	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—PIK3R1—hematologic cancer	2.21e-06	4.15e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—NCOR1—hematologic cancer	2.21e-06	4.15e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—GSTM1—hematologic cancer	2.21e-06	4.15e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—SRC—hematologic cancer	2.21e-06	4.15e-05	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—PIK3CD—hematologic cancer	2.21e-06	4.14e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—PIK3CA—hematologic cancer	2.2e-06	4.12e-05	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—HRAS—hematologic cancer	2.19e-06	4.1e-05	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—ALB—hematologic cancer	2.18e-06	4.09e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—SRC—hematologic cancer	2.18e-06	4.08e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—VEGFA—hematologic cancer	2.15e-06	4.04e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—STAT3—hematologic cancer	2.13e-06	4e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—NRAS—hematologic cancer	2.13e-06	3.99e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—TP53—hematologic cancer	2.13e-06	3.99e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—VEGFA—hematologic cancer	2.12e-06	3.98e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—STAT3—hematologic cancer	2.1e-06	3.94e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—NRAS—hematologic cancer	2.09e-06	3.93e-05	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—IL6—hematologic cancer	2.09e-06	3.92e-05	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—PIK3R1—hematologic cancer	2.09e-06	3.91e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—KRAS—hematologic cancer	2.09e-06	3.91e-05	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—PIK3CB—hematologic cancer	2.04e-06	3.83e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—MAPK3—hematologic cancer	2.04e-06	3.82e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—HRAS—hematologic cancer	2.03e-06	3.82e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—MAPK3—hematologic cancer	2.01e-06	3.76e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—MYC—hematologic cancer	1.98e-06	3.72e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—TGFB1—hematologic cancer	1.98e-06	3.71e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—MTHFR—hematologic cancer	1.96e-06	3.67e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—MYC—hematologic cancer	1.95e-06	3.66e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—IL6—hematologic cancer	1.95e-06	3.65e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—TGFB1—hematologic cancer	1.95e-06	3.65e-05	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—AKT1—hematologic cancer	1.93e-06	3.62e-05	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—PIK3CB—hematologic cancer	1.93e-06	3.61e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—PIK3CA—hematologic cancer	1.92e-06	3.59e-05	CbGpPWpGaD
Buspirone—CYP3A7—Metabolism—AKT1—hematologic cancer	1.87e-06	3.5e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—TP53—hematologic cancer	1.85e-06	3.48e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—KRAS—hematologic cancer	1.83e-06	3.43e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—KRAS—hematologic cancer	1.8e-06	3.38e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—AKT1—hematologic cancer	1.8e-06	3.37e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—HRAS—hematologic cancer	1.77e-06	3.33e-05	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—PTEN—hematologic cancer	1.77e-06	3.31e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—IL6—hematologic cancer	1.7e-06	3.18e-05	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—EP300—hematologic cancer	1.68e-06	3.16e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—PIK3CA—hematologic cancer	1.68e-06	3.16e-05	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—PTEN—hematologic cancer	1.66e-06	3.12e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—PIK3CA—hematologic cancer	1.66e-06	3.1e-05	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—PIK3CA—hematologic cancer	1.65e-06	3.1e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—PIK3CG—hematologic cancer	1.64e-06	3.08e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—TP53—hematologic cancer	1.63e-06	3.05e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—TP53—hematologic cancer	1.6e-06	3e-05	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—EP300—hematologic cancer	1.59e-06	2.98e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—AKT1—hematologic cancer	1.57e-06	2.94e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—HRAS—hematologic cancer	1.56e-06	2.92e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—HRAS—hematologic cancer	1.53e-06	2.87e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—CREBBP—hematologic cancer	1.52e-06	2.86e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—IL6—hematologic cancer	1.49e-06	2.79e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—IL6—hematologic cancer	1.47e-06	2.75e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—PIK3CD—hematologic cancer	1.44e-06	2.71e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—ALB—hematologic cancer	1.43e-06	2.67e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—AKT1—hematologic cancer	1.37e-06	2.58e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—PIK3R1—hematologic cancer	1.36e-06	2.56e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—AKT1—hematologic cancer	1.35e-06	2.54e-05	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—AKT1—hematologic cancer	1.35e-06	2.53e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—PIK3CB—hematologic cancer	1.26e-06	2.36e-05	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—PIK3CA—hematologic cancer	1.25e-06	2.34e-05	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—PIK3CA—hematologic cancer	1.17e-06	2.2e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—PTEN—hematologic cancer	1.09e-06	2.04e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—EP300—hematologic cancer	1.04e-06	1.95e-05	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—AKT1—hematologic cancer	1.02e-06	1.91e-05	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—AKT1—hematologic cancer	9.59e-07	1.8e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—PIK3CA—hematologic cancer	7.68e-07	1.44e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—AKT1—hematologic cancer	6.27e-07	1.18e-05	CbGpPWpGaD
